阿替唑单抗
医学
三阴性乳腺癌
紫杉醇
肿瘤科
乳腺癌
内科学
激素受体
紫杉醇
癌症研究
癌症
免疫疗法
彭布罗利珠单抗
作者
Peter Schmid,Sylvia Adams,Hope S. Rugo,Andreas Schneeweiss,Carlos H. Barrios,Hiroji Iwata,Véronique Dièras,Roberto Hegg,Seock‐Ah Im,Gail S. Wright,Volkmar Henschel,Luciana Molinero,Jane Yuet Ching Hui,Roel Funke,Amreen Husain,Eric P. Winer,Sherene Loi,Leisha A. Emens
标识
DOI:10.1056/nejmoa1809615
摘要
Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)–paclitaxel may enhance the anticancer activity of atezolizumab.
科研通智能强力驱动
Strongly Powered by AbleSci AI